CEOInterviews.AI
Start App
Will Ahmed
Founder & CEO, WHOOP

The Blood Biomarkers that Prevent Disease Years Before Symptoms

📅 Apr 22, 2026 WHOOP 38 MIN 3553 VIEWS 69 SEGMENTS · 2 SPEAKERS
In this episode of the WHOOP Podcast, WHOOP Founder and CEO Will Ahmed sits down with Quest Diagnostics CEO Jim Davis to discuss the partnership behind WHOOP Advanced Labs. Will and Jim discuss how combining blood biomarkers with continuous physiological data is reshaping consumer health. Will and Jim explore how trends in metrics like cholesterol, glucose, sleep, and recovery can drive more personalized, actionable insights and help shift healthcare from reactive to preventative. Jim shares his personal approach to health tracking, his vision for democratizing lab testing, and leadership less...

Questions asked in this interview

12
  1. 3:03What do you need to do on the sleep side?' Right?
  2. 7:48There's then — why else do people go to the doctor?
  3. 15:30You are on the leading edge here and what's really exciting about this space is as a company — how old are you, Will?
  4. 15:40So why do I have to go to a doctor to check my A1C level or my LDL?
  5. 17:36Do we develop better technologies, better drugs, better things to take care of all these chronic conditions?
  6. 19:30But the big thing, you know, lack of sleep, lack of exercise, poor nutrition, it's going to lead to inflammation in the human body. Okay?
  7. 23:05Now look, mammography, it's X-ray, right?
  8. 24:21It's a wide range of categories, right?
  9. 28:02All of those things you can check in your blood work to know should I be taking a B12 supplement?
  10. 30:07How much stress did I have?
  11. 31:20But more and more I am trying to use the data to sort of modify my workouts to, you know, to reflect is this a good day or a bad day or should I take it a little easier?
  12. 35:20So I want to do something better today than I did yesterday and I want to do something better tomorrow than I did today. Combine that with curiosity, right?
Jim 0:00 ↗
The number one killer in the US today is heart disease. With any disease, we always know earlier detection is better versus late stage detection. Cancer for sure, diabetes for sure. Our goal as a company is to get more people to do the general screening and wellness so that we're not doing all of this later stage disease. And I know that's your goal, too.
Will Ahmed 0:20 ↗
You've been the CEO of Quest now for over 3 years. We're very grateful to be partners with you. You all have created a very seamless experience for our members to go and have access to their biomarkers. And we of course are excited now that this data is woven into the Whoop app and the 24/7 physiological data. This partnership is exactly what health and wellness consumers really want and need.
Jim 0:44 ↗
So much of our testing today, Will, is for sickness. What we have to do is get out in front of this and focus on basic prevention and wellness. To change the healthcare trends in this country, we have to have action from those insights, and you're the guys that are going to help create the motivation for people to take action.
Will Ahmed 1:01 ↗
What's your hope for how consumers are going to be using this product integration in order to prevent these chronic conditions? Here's what you need to do.
Jim, welcome to the podcast.
Jim 1:14 ↗
Hey, thanks Will. It's great to be here. Great to be back in Boston.
Will Ahmed 1:17 ↗
You've got an amazing journey and first and foremost I want to talk about the Whoop Quest partnership because we're very grateful to be partners with you. I think historically when people think of blood tests they're thinking of a hospital environment or a doctor's office and in some ways we've flipped the script together. This is something that's very consumer-facing. It's designed to be friendly. You all have created a very seamless experience for our members to go and have access to their biomarkers and we of course are excited now that this data is woven into the Whoop app and the 24/7 physiological data. So when you first saw this concept of Whoop Advanced Labs and the partnership, what came to mind for you?
Jim 2:02 ↗
Well, I was thrilled to be part of this. Number one, I'm a very active person. I run, swim, work out. It's just part of my life. It's part of who I am.
Will Ahmed 2:14 ↗
And by the way, for our listeners, Jim's got an eight-year or younger health span score on Whoop. So, he showed me his data. I can validate this. He is very healthy and fit.
Jim 2:24 ↗
Yeah. So, you know, I've long tracked things in my body. I'm a little bit obsessive myself. I weigh myself every day, sometimes twice a day. I monitor what I eat. I monitor a lot of things. So, you know, being able to now correlate physiological measurements with my actual biomarkers with the purpose of trying to give feedback to help me optimize those biomarkers is what it's all about. This partnership, I think, is exactly what health and wellness consumers really want and need.
Will Ahmed 2:59 ↗
What's your hope for how consumers are going to be using this product integration?
Jim 3:03 ↗
If we think about this in mathematical terms, and I don't mean to be — I'm a mathematician by background. You think about this simple equation: y is a function of x, right? y is an outcome and it's a function of different variables, x1, x2, x3, x4. I went over to MIT for school. So again, what are we trying to do here? Right, the Y variables are your actual biomarkers. Okay, it's your A1C, it's your C-reactive protein, it's your LDL, HDL, and we'll talk more about what these panels are. And those are the things that you're trying to optimize. And your X variables are what you're measuring. It's your heart rate variability, it's your stress, it's your pulse, it's your sleep patterns, it's nutrition. Absolutely. Those are all your X variables. And so what we want to do is correlate those X variables, all the things that you're measuring, with the ultimate measures on what's going on inside your human body. Now, where we want to get, and I think what's going to be great with this partnership, is to then give that consumer feedback and say, 'This is what — if you really want to drop your A1C value, if you want to optimize your LDL and HDL or whatever biomarker you're trying to optimize, here's what you need to do. How do you get your heart rate variability up? What do you need to do on the sleep side?' Right? So ultimately we want to develop algorithms with you that give feedback so that the user can optimize, you know, the X variables to get what they want from a health perspective. Makes sense.
Will Ahmed 4:43 ↗
Makes perfect sense. I mean that's part of why I'm so excited about it. I think like a lot of people who care about their health, I've had a bunch of blood tests in my life that were sort of floating around my desk or somewhere in my inbox. The ability to upload all of those prior tests into the Whoop app as part of this and then to go do a Quest test — now it's all integrated together in one place. And so I can see my trends over time. And I can also then talk to Whoop in the app about, you know, to your point, how has my sleep been affecting my cholesterol level or fill in the blank and so on and so forth.
Jim 5:20 ↗
Yeah. What's really important in lab testing is never just one point in time. And that's why we think your subscription makes sense. There's certain things you're fine to check once a year, but there's certain things, especially if you're trying to improve your health, that you do perhaps want to check once a quarter or once every six months. And we talk in Quest Diagnostics a lot about the velocity or the change of your parameters. And very often, you know, when we get lab work done through a physician office, they get the results and they're really just looking at those results at one point in time. It's static. But when you put together a history over a year, two years, three years, four years, five years, and you start to look at the trends, it's really the velocity, the rate of change that can really give you signals about, you know what, you're two years away from being a diabetic. You're two years away from having coronary artery disease.
Will Ahmed 6:17 ↗
So important.
Jim 6:17 ↗
Is so important. Okay. And so knowing, you know, looking at these values, you know, frequently looking at them over time and then again marrying those with the physiological data is what's hopefully going to give people the impetus to change. In Quest, we have this saying, we call it action from insights. And what we do is honestly we provide the insights. What you do is you can provide the action because you can give that feedback to the user based on their lab data. Here's what you need to change in order to optimize these set of biomarkers.
Will Ahmed 6:52 ↗
Well, I love what you said about the trends because I think that's such a critical point. Often it takes some time to meaningfully move something that might be way out of range to being sufficient to then being optimal. And so seeing the direction of that change is really pretty critical. And it reminds me too of, you know, when I was founding Whoop, one of the things that we were obsessed with was this idea of continuous health data. You know, historically medical health data would come in these little snippets. You walk into a doctor's office once a year and they take your pulse ox and your blood pressure, like okay, right, your heart rate data might be captured by a chest strap when you're exercising and then nothing else. And so a big theme for Whoop has been this idea of continuous data. And I hear the way you think about Quest in a similar way, which is it's not a picture, it's a movie, right? You want to see the evolution over time.
Jim 7:48 ↗
It's exactly right. It is a movie. And you know again, whether it's A1C, LDL, HDL, you know for men PSA, an important measure, watching these things over time with AI, with intelligence, we can get to the point of predicting when you know something is going to happen if you don't change that trend. And again, that's where it comes back. And look, for most of the things we're talking about, you can change all of those biomarkers. You know, when we think about what do you guys really measure, you know, the lab data that you're measuring, there's really four basic things, right? You're measuring cardiac health, lipids, okay, LDL, HDL, two very important tests by the way that you have added, which congratulations for doing this. LP little a and ApoB are two incredibly important cardiac biomarkers that, you know what, the normal world isn't — most physicians don't order those tests. Why don't they order them? Because the commercial payers don't pay for those tests. So they're largely missed, but two very important variables. So cardiac health is always number one. Second is your metabolic health. How are your kidneys performing? How is your liver performing? And then it's really the combination of cardiac, liver, kidney. We call it cardiometabolic. But for you guys, two separate panels: a lipid panel and then a complete metabolic panel. The third very important thing is then just looking at your blood: white blood cell count, red blood cell count, the components of white blood cells, the components of red blood cells. That really gives you an indication of your immune system. How is your immune system reacting to normal bacteria, viruses, normal environmental factors? And so also, and that's also on your panel, we call it the CBC, complete blood count. And then really the last thing is then let's just look at some basic vitamin levels: vitamin D, B12, folates, and maybe there's some things in those panels around thyroid, kind of regulates the body, and making sure your thyroid — you've got a great panel assembled that can really help people assess their general health and wellness. As a company, that's what we want, right? So much of our testing today, Will, is for sickness. And if you think about the health journey, right? There's basic prevention and wellness. We wish more people would do more of that. But there's general health and wellness. There's then — why else do people go to the doctor? They go because they're sick. So then if you think about the next phase, it's diagnosis of disease. A lot of blood testing and a lot of lab work is ordered to diagnose disease. Now once that disease is diagnosed there's still going to be lab testing because now you have to figure out well what is the right therapy that we should apply to that disease and very often lab tests are used to help the doctor determine what type of therapy. And then there's what we call disease monitoring. You have a disease, it could be viral, it could be bacterial, could be cancer, but you want to monitor the progression of that disease. Our goal as a company is to get more people to do the general screening and wellness so that we're not doing all of this later stage disease, and I know that's your goal too. So this we call this thing action from insight. We'll give the insights, we want you to give the actions.
Will Ahmed 11:20 ↗
It's a really amazing vision that you have for this. For you personally, what are the specific biomarkers you like to look at and how often are you looking at them?
Jim 11:30 ↗
Well, I look at those three basic panels. I probably — I'm a little more overboard, but look, I work for a lab company, so it's easy enough for me to get tested. But I probably check those three panels at least once a quarter. Look, I'll do other tests that Quest Diagnostics may not even offer. I just did the Grail test, which is an early cancer detection test. I did it just to try it out. We also offer the test on our menu as a company even though it's performed by the Grail Lab. It's really those basic panels that I do. Now, I'll interrogate certain vitamins. I'll interrogate a little more my thyroid function, but it's those basic panels that I try to run once a quarter.
Will Ahmed 12:11 ↗
What do you feel are some of the challenges with building out this technology? I mean, you and I think agree that doing these panels on a quarterly basis or, you know, maybe twice a year, it's going to be an amazing screening tool for the entire population. What are some of the challenges for you as a business like scaling that and maintaining that? We were talking about the sophistication of your labs.
Jim 12:37 ↗
Well, there's really not that many challenges. We didn't discuss too much about who Quest is. Look, we're a national company. We've got — first of all we've been around, Will, for 60 years. We started as a little lab in New York City, became a bigger lab in the northeast, and then over time we built out laboratories across the United States. The other thing I want Whoop users to know: you're not dealing with some fly-by-night medical laboratory, medical technology company. This is a company with over 750 MD PhDs in the company. We develop our own tests and you know on an annual basis, in 2025 we did upwards of 225 million requisitions. Each requisition represents a human life. Now we didn't do 225 million unique people in the US and Canada. We have repeat users obviously, but we tested over one-third of the US adult population last year.
Will Ahmed 13:39 ↗
That's amazing, isn't it?
Jim 13:40 ↗
It is amazing. And so now we got to get the other two-thirds, by the way.
Will Ahmed 13:44 ↗
Exactly.
Jim 13:45 ↗
We'll work on that this year. And so many of your Whoop users I'm sure are already Quest Diagnostics customers, which is great because now they have serial comparisons. They have that data over time. But you're dealing with a trusted medical provider. The reality is 90-95% of our business comes from physicians and comes from hospitals. And the specimens we collect in our patient service centers, they are tested at the exact same time, same locations across the US as every other physician order or hospital order. So there really hasn't been many — I wouldn't say there's any technical issues in terms of collecting the blood. There's over 2,000 patient service centers where you go, we collect the blood. I don't think there's any technical challenges there. I think what's going to be exciting in the future is when you and I and our teams build out these algorithms, what I call these feedback loops, you know, really specifically giving people advice on movement, sleep, stress, the things that can impact your heart rate variability, your stress, your recovery. We want to give people feedback on what they need to do in order to again optimize those biomarkers.
Will Ahmed 14:55 ↗
It makes a lot of sense and it's an amazing company. I mean 60 years old, lab tests for a third of Americans, and my hunch is that'll grow to be at least two-thirds in the coming years or decade.
Jim 15:08 ↗
We hope.
Will Ahmed 15:09 ↗
Yeah. And then obviously you're working with innovative partners like Whoop who, you know, are very consumer-facing and I think we represent this kind of new age of medicine or what it can be, which is putting everyone's health data in one place and then giving them the tools and the AI or the coaching to understand all of that data to know what to do with it.
Jim 15:30 ↗
Yeah. You are on the leading edge here and what's really exciting about this space is as a company — how old are you, Will?
Will Ahmed 15:38 ↗
13 years.
Jim 15:39 ↗
13 years. Okay. Yeah.
Believe it or not, a consumer could not get lab testing in this country until 2014 or 2015. It was regulated by the government, federal government, and by the states. And so, the only way you could look at what's going on inside your human body was to go to a physician and to get an order for that lab work. Now, we still think physicians and hospitals are an incredibly important aspect. And there's some lab tests, by the way, that you should show to your physician and you should get physician input. But for some things like A1C, LDL, CRP, blood chemistry, why should that be difficult? And you're making it easy, which is what we love about this partnership, right? We want people to interrogate and look inside their human body. As I said, I get on a scale every single day. I don't need a doctor's order for that, right? I don't need a doctor's order to check my pulse. I don't need a doctor's order to check my blood pressure. So why do I have to go to a doctor to check my A1C level or my LDL? And now again, you marry your physiological data with these biomarkers and it's just going to open up a revolution here. And what we hope is that all these sickness trends, you know, it's going to become wellness trends.
Will Ahmed 16:59 ↗
It has to. I mean, it doesn't make any sense how sick the American population is. There was an announcement just yesterday around wearable data and using wearables to have more access to health data. And that, you know, before, the regulatory environment for Whoop was pretty complicated for us working with the FDA, and they've come out with I think some really useful new guidance which allows this data to be more accessible. So that's in some ways our version of the 2014 thing that you just mentioned where, hey, this wasn't easily available to consumers before, and so government regulation does play an important role in what you call the revolution, and I agree with that.
Jim 17:36 ↗
Yeah, I think there's a recognition at the federal level now that we need to empower consumers to take charge of their own health care with the technology that exists, with AI coaches that exist. Again, we're not suggesting replace doctors, replace hospitals. They're an absolutely needed, important resource in our health care system. But look, at the end of the day, if we don't do anything as a country, what we're seeing right now is that baby boomer generation that's aging into Medicare, that's turning 65, they're coming in with two chronic conditions, three chronic conditions, four chronic conditions. And the reality is we as a country have developed some amazing technology to keep people alive and to treat these chronic conditions. But it's just costing more and more money and we will ultimately bankrupt Medicare if we don't do anything about it. So what do you do about it? Do we develop better technologies, better drugs, better things to take care of all these chronic conditions? No. That's not the answer. That's not going to fix the problem. What we have to do is get out in front of this and focus on things like nutrition, exercise, sleep, stress, mental illness. Those are the things that we have to focus on so that we prevent these chronic conditions and the people again hopefully in the next generation, you know, in 25 years, those aging into Medicare are going to be a much healthier lot of people.

34 more exchanges in this transcript

Sign in free to read the rest of this interview. No card required.

Sign in to read the full transcript

Cite this transcript

APA, MLA, BibTeX
APA

Ahmed, W. (2026, April 22). The Blood Biomarkers that Prevent Disease Years Before Symptoms [Interview transcript]. WHOOP. CEOInterviews.AI. https://ceointerviews.ai/interview/3172979/

MLA

Will Ahmed. "The Blood Biomarkers that Prevent Disease Years Before Symptoms." WHOOP, 22 Apr. 2026. Transcript, CEOInterviews.AI, https://ceointerviews.ai/interview/3172979/.

BibTeX
@misc{ahmed2026_3172979,
  author       = {Will Ahmed},
  title        = {The Blood Biomarkers that Prevent Disease Years Before Symptoms},
  howpublished = {Interview transcript, WHOOP. CEOInterviews.AI},
  year         = {2026},
  month        = {apr},
  url          = {https://ceointerviews.ai/interview/3172979/},
  note         = {Speaker-attributed transcript with timestamps}
}